MCL1 inhibitor BRD-810 kills most cancers cells even though minimizing chance of cardiotoxicity The anti-apoptotic protein MCL1 can be a therapeutic goal in cancer, but long-time period MCL1 inhibition has become uncovered to raise the threat of cardiotoxicity. . For example, federal suggestions for specific vaccines boost the demand for anyone